{"id":384954,"date":"2020-11-19T08:04:38","date_gmt":"2020-11-19T13:04:38","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=384954"},"modified":"2020-11-19T08:04:38","modified_gmt":"2020-11-19T13:04:38","slug":"cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/","title":{"rendered":"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n HOUSTON<\/span>, Nov. 19, 2020<\/span> \/PRNewswire\/ —\u00a0CNS Pharmaceuticals, Inc.<\/b><\/a>\u00a0<\/b>(NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its joint sponsorship with WPD Pharmaceuticals for the 2020 Society of NeuroOncology (SNO) Virtual Meeting held November 19-21, 2020<\/span>. <\/p>\n

\n

\n
\n \"(PRNewsfoto\/CNS
\n <\/a>\n <\/p>\n<\/p><\/div>\n

CNS and WPD’s joint sponsorship is on the Supporter’ level, which includes a booth in the virtual exhibit hall. Dr. Patrick Wen<\/span>, Director of Center for Neuro-Oncology at Dana-Farber Cancer Institute and member of CNS Pharmaceuticals’ Science Advisory Board, will be participating in a panel discussion on clinical trials during the plenary session on Friday, November 20<\/span>, as well as in online poster presentations.<\/p>\n

\n About CNS Pharmaceuticals, Inc<\/b>.<\/p>\n

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals, Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006. In this trial the overall response rate of stable disease or better was 44%. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of Feb. 20, 2020<\/span>. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. By the end of 2020, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the U.S., while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland<\/span>. Its second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation.<\/p>\n

For more information, please visit\u00a0www.CNSPharma.com<\/a>.<\/p>\n

\n About WPD Pharmaceuticals\u00a0<\/b>\n <\/p>\n

WPD is a biotechnology research and development company with a focus on oncology and virology, namely research and development of medicinal products involving biological compounds and small molecules. WPD has licensed in certain countries 10 novel drug candidates with 4 that are in clinical development stage. These drug candidates were researched at medical institutions, and WPD currently has ongoing collaborations with Wake Forest University<\/span> and leading hospitals and academic centers in Poland.\u00a0<\/p>\n

WPD has entered into license agreements with Wake Forest University<\/span> Health Sciences and sublicense agreements with Moleculin Biotech, Inc. and CNS Pharmaceuticals, Inc., respectively, each of which grant WPD an exclusive, royalty-bearing sublicense to certain\u00a0compounds for about 30 countries, mostly in Europe<\/span>. Such agreements provide WPD with certain research, development, manufacturing and sales rights\u00a0and obligations, among other things.\u00a0<\/p>\n

For more information, please visit wpdpharmaceuticals.com<\/a>. <\/p>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting-301176680.html<\/a><\/p>\n

SOURCE CNS Pharmaceuticals, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire HOUSTON, Nov. 19, 2020 \/PRNewswire\/ —\u00a0CNS Pharmaceuticals, Inc.\u00a0(NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its joint sponsorship with WPD Pharmaceuticals for the 2020 Society of NeuroOncology (SNO) Virtual Meeting held November 19-21, 2020. CNS and WPD’s joint sponsorship is on the Supporter’ level, which includes a booth in the virtual exhibit hall. Dr. Patrick Wen, Director of Center for Neuro-Oncology at Dana-Farber Cancer Institute and member of CNS Pharmaceuticals’ Science Advisory Board, will be participating in a panel discussion on clinical trials during the plenary session on Friday, November 20, as well as in online … <\/p>\n

Continue reading “CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-384954","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire HOUSTON, Nov. 19, 2020 \/PRNewswire\/ —\u00a0CNS Pharmaceuticals, Inc.\u00a0(NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its joint sponsorship with WPD Pharmaceuticals for the 2020 Society of NeuroOncology (SNO) Virtual Meeting held November 19-21, 2020. CNS and WPD’s joint sponsorship is on the Supporter’ level, which includes a booth in the virtual exhibit hall. Dr. Patrick Wen, Director of Center for Neuro-Oncology at Dana-Farber Cancer Institute and member of CNS Pharmaceuticals’ Science Advisory Board, will be participating in a panel discussion on clinical trials during the plenary session on Friday, November 20, as well as in online … Continue reading "CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-19T13:04:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1120277\/CNS_Pharmaceuticals_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting\",\"datePublished\":\"2020-11-19T13:04:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/\"},\"wordCount\":524,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1120277\\\/CNS_Pharmaceuticals_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/\",\"name\":\"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1120277\\\/CNS_Pharmaceuticals_Logo.jpg\",\"datePublished\":\"2020-11-19T13:04:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1120277\\\/CNS_Pharmaceuticals_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1120277\\\/CNS_Pharmaceuticals_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting - Market Newsdesk","og_description":"PR Newswire HOUSTON, Nov. 19, 2020 \/PRNewswire\/ —\u00a0CNS Pharmaceuticals, Inc.\u00a0(NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its joint sponsorship with WPD Pharmaceuticals for the 2020 Society of NeuroOncology (SNO) Virtual Meeting held November 19-21, 2020. CNS and WPD’s joint sponsorship is on the Supporter’ level, which includes a booth in the virtual exhibit hall. Dr. Patrick Wen, Director of Center for Neuro-Oncology at Dana-Farber Cancer Institute and member of CNS Pharmaceuticals’ Science Advisory Board, will be participating in a panel discussion on clinical trials during the plenary session on Friday, November 20, as well as in online … Continue reading \"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-19T13:04:38+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1120277\/CNS_Pharmaceuticals_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting","datePublished":"2020-11-19T13:04:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/"},"wordCount":524,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1120277\/CNS_Pharmaceuticals_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/","name":"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1120277\/CNS_Pharmaceuticals_Logo.jpg","datePublished":"2020-11-19T13:04:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1120277\/CNS_Pharmaceuticals_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1120277\/CNS_Pharmaceuticals_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cns-pharmaceuticals-and-wpd-pharmaceuticals-to-contribute-sponsorship-to-2020-sno-virtual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=384954"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384954\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=384954"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=384954"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=384954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}